Form 4 for IDXX Idexx Laboratories
Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-12 · accession 0000874716-26-000018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-17 | 2026-02-14 | IDXX | Emerson Andrew | EVP, CFO, Treas | M - OptEx | $0.00 | +456 | 4,044 | +13% | $0 |
| D | 2026-02-17 | 2026-02-14 | IDXX | Emerson Andrew | EVP, CFO, Treas | F - Tax | $629.35 | -123 | 4,222 | -3% | -$77.4K |
| DM | 2026-02-17 | 2026-02-12+ | IDXX | Emerson Andrew | EVP, CFO, Treas | M - OptEx | $0.00 | -456 | 581 | -44% | $0 |
| DM | 2026-02-17 | 2026-02-12 | IDXX | Emerson Andrew | EVP, CFO, Treas | A - Grant | $0.00 | +5,445 | 284 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-14 | M | A | 194 | $0.00 | 4,280.44 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-14 | M | A | 42 | $0.00 | 4,086.44 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-14 | F | D | 123 | $629.35 | 4,222.44 | D | — | — | (F3) Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026. (F4) Includes 65 vested but deferred RSUs. |
| 4 | Common | Common Stock | 2026-02-14 | M | A | 61 | $0.00 | 3,950.44 | D | — | — | (F1) Includes a total of 18.666 shares purchased under the Issuer Employee Stock Purchase Plan on September 30, 2025 and December 31, 2025. |
| 5 | Common | Common Stock | 2026-02-14 | M | A | 65 | $0.00 | 4,345.44 | D | — | — | (F2) Represents Restricted Stock Units ('RSU') that were granted on February 14, 2025, were deferred in accordance with the Issuer's Deferred Compensation Plan and have vested. Upon vesting, these RSUs were recorded in an account under such Plan and represents a contingent right to receive one share of Issuer common stock that is payable as soon as practicable after the reporting person's separation of service with the Issuer or a date specified by the reporting person. |
| 6 | Common | Common Stock | 2026-02-14 | M | A | 94 | $0.00 | 4,044.44 | D | — | — | |
| 7 | Derivative | Restricted Stock Unit | 2026-02-14 | M | D | 42 | $0.00 | 83 | D | — · — to — | 42 Common Stock | (F12) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025. |
| 8 | Derivative | Restricted Stock Unit | 2026-02-14 | M | D | 94 | $0.00 | 93 | D | — · — to — | 94 Common Stock | (F11) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2024. |
| 9 | Derivative | Restricted Stock Unit | 2026-02-14 | M | D | 61 | $0.00 | 0 | D | — · — to — | 61 Common Stock | (F10) Represents RSUs that were granted on February 14, 2025 and deferred in accordance with the Issuer's Deferred Compensation Plan and represents a contingent right to receive one share of Issuer common stock vesting in four annual installments, beginning February 14, 2026. Upon vesting, each such RSU will be recorded in an account under such Plan. |
| 10 | Derivative | Restricted Stock Unit | 2026-02-12 | M | D | 65 | $0.00 | 193 | D | — · — to — | 65 Common Stock | (F9) Represents RSUs that were granted on February 14, 2025 and deferred in accordance with the Issuer's Deferred Compensation Plan and represents a contingent right to receive one share of Issuer common stock vesting in four annual installments, beginning February 14, 2026. Upon vesting, each such RSU will be recorded in an account under such Plan. |
| 11 | Derivative | Restricted Stock Unit | 2026-02-14 | M | D | 194 | $0.00 | 581 | D | — · — to — | 194 Common Stock | (F13) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2026. |
| 12 | Derivative | Restricted Stock Unit | 2026-02-12 | A | A | 729 | $0.00 | 729 | D | — · — to — | 729 Common Stock | (F7) Each RSU represents a contingent right to receive one share of Issuer common stock that vests in four annual installments, beginning February 14, 2027. |
| 13 | Derivative | Incentive Stock Option (right-to-buy) | 2026-02-12 | A | A | 162 | $0.00 | 162 | D | $617.20 · — to 2036-02-11 | 162 Common Stock | (F6) Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030. |
| 14 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2026-02-12 | A | A | 4,270 | $0.00 | 4,270 | D | $617.20 · — to 2036-02-11 | 4,270 Common Stock | (F5) Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027. |
| 15 | Derivative | Restricted Stock Unit | 2026-02-12 | A | A | 284 | $0.00 | 284 | D | — · — to — | 284 Common Stock | (F8) Grant of RSUs that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in four annual installments, beginning February 14, 2027. |